
A genetic mutation linked to Parkinson’s disease produced abnormalities in a subset of nerve cells, offering a clue about the disease’s causes, according to a new study published in the Proceedings of the National Academy of Sciences.

A new Northwestern study has shown for the first time how toddlers’ brains respond during natural moments of play with their parent or caregiver.

Taking opioids for years does not seem to improve pain and functioning in people with chronic back pain, according to a new Northwestern University study.

A new artificial intelligence tool developed by Northwestern Medicine scientists and collaborating institutions can help determine whether genetic variants associated with a severe form of childhood epilepsy will actually cause disease, according to a study published in the Journal of Clinical Investigation.

Loneliness can reprogram the brain in ways that push alcohol consumption, reports a new preclinical study led by Northwestern University and the Salk Institute for Biological Studies.

Every 40 seconds, someone in the U.S. has a stroke, according to the Centers for Disease Control and Prevention. Investigators at Feinberg are working from multiple angles of the stroke care pathway, leading to research that may improve recovery after a stroke occurs.

A landmark international study has found that the genetic drivers of Parkinson’s disease can vary dramatically between populations, underscoring the need to include people of various ancestries in genetic research and clinical trials.

Northwestern Medicine scientists have uncovered how a major Parkinson’s disease gene disrupts the brain’s most vulnerable dopamine-producing neurons before detectable neuronal loss, according to findings published in Nature Communications.

Farrah Mateen, MD, PhD, chief of the Division of Multiple Sclerosis & Neuroimmunology and the Dr. Charles L. Mix Research Professor of Neurology, has been named director of the Center for Global Neurology, a center of the Robert J. Havey, MD Institute for Global Health (IGH).

A new study has identified mutations in a single gene as the cause of a previously unrecognized spectrum of severe neurological disorders, according to a study published in the Journal of Clinical Investigation.